Omada Health v Hinge Health Health v Doctolib financials and IPO prospects Omada Health v Hinge Health v Doctolib financials and IPO...

Hinge Health and Omada Health IPOs set to increase HealthTech M&A multiples by boosting sector confidence Hinge Health and Omada Health...

Rubric evaluations: the next frontier in Healthcare AI Rubric evaluations: the next frontier in Healthcare AI Rubric evaluations, as...

HealthBench: OpenAI’s first major Healthcare AI initiative HealthBench: OpenAI’s first major Healthcare AI initiative HealthBench is an...

NHS ConfedExpo 2025: What are the key talking points likely to be? NHS ConfedExpo 2025: What are the key talking points likely to be? The...

Polypills and Cardiovascular Innovation: HealthTech market to watch in 2025 Polypills and Cardiovascular Innovation: HealthTech market to...

Nelson Advisors partner Lloyd Price and a panel of HealthTech CEO's and Founders debated a range of topics at The Future Health event in...

Neighbourhood Health: What do HealthTech suppliers need to think about following the recent ICB National Footprint guidance?...

Continuous Glucose Monitoring - where is the evidence for CGM as a HealthTech sub market? Continuous Glucose Monitoring - where is the...

What exactly is Consumer HealthTech? What exactly is Consumer HealthTech? Consumer HealthTech refers to digital tools and technologies...

Exec Summary: The HealthTech M&A landscape in 2025 is characterised by a mix of opportunity and caution. While innovative technologies...

Nelson Advisors partner Lloyd Price has been invited to Judge the HealthInvestor 2025 Awards for the second year in a row and third time...

Exec Summary: Looking ahead into 2025, the UK HealthTech market is on track to continue growing and evolving around four main themes,...

Exec Summary: The intersection of neuroscience and technology has given rise to a groundbreaking field known as Brain-Computer Interfaces...

The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health